Armistice Capital, LLC 13D and 13G filings for AIM ImmunoTech Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:55 pm Sale |
2024-12-31 | 13G | AIM ImmunoTech Inc. AIM |
Armistice Capital, LLC | 3,349,740 4.990% |
-980,260![]() (-22.64%) |
Filing |
2024-11-14 3:21 pm Purchase |
2024-09-30 | 13G | AIM ImmunoTech Inc. AIM |
Armistice Capital, LLC | 4,330,000 6.840% |
4,330,000![]() (New Position) |
Filing |